Compare ABT & BN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABT | BN |
|---|---|---|
| Founded | 1888 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9B | 108.6B |
| IPO Year | 2006 | 1998 |
| Metric | ABT | BN |
|---|---|---|
| Price | $116.50 | $41.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 7 |
| Target Price | ★ $130.90 | $49.87 |
| AVG Volume (30 Days) | ★ 5.9M | 4.3M |
| Earning Date | 04-16-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.76% | 0.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $44,328,000,000.00 | N/A |
| Revenue This Year | $10.75 | N/A |
| Revenue Next Year | $8.10 | $16.74 |
| P/E Ratio | $191.20 | ★ $93.92 |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $81.97 | $37.93 |
| 52 Week High | $137.49 | $74.20 |
| Indicator | ABT | BN |
|---|---|---|
| Relative Strength Index (RSI) | 75.76 | 41.88 |
| Support Level | $111.18 | $41.61 |
| Resistance Level | $116.82 | $47.40 |
| Average True Range (ATR) | 2.18 | 0.94 |
| MACD | 0.26 | -0.25 |
| Stochastic Oscillator | 90.79 | 14.82 |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals, operating through seven segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity (which generates the highest revenue), Real Estate, and Corporate Activities. The company invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders, with the majority of its revenue coming from Asset Management. It has a presence across the United Kingdom, the United States (which contributes the highest revenue), Australia, Canada, Brazil, India, Colombia, Germany, other parts of Europe, other parts of Asia, and additional countries.